-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Zymeworks, Raises Price Target to $56

Benzinga·11/10/2026 11:44:16
Diffusion vocale
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $55 to $56.